NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs071190020

Registered date:13/08/2019

Fasciolosis treatment with Egaten

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedFasciolosis
Date of first enrollment30/08/2019
Target sample size33
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Treatment with un-licensed medicine

Outcome(s)

Primary Outcomeefficacy rate
Secondary Outcome1) Decrease in size of hepatic lesion in abdominal CT 2) Decrease in size of Parasite clearance time 3) Appearance of abdominal symptoms 4) Appearance of hepatic dysfunction 5) Appearance of skin eruption

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderBoth
Include criteria1) Patients who are diagnosed as having fasciolosis 2) Patients who give written informed consent 3) Informed consent from proxies are obtained
Exclude criteria1) Patients who are allergic to Triclabendazole 2) Patients who are pregnant, or possibly pregnant 3) Patients who does not give written informed consent 4) Patients principal investigator judged inappropriate

Related Information

Contact

Public contact
Name Haruhiko Maruyama
Address 5200 Kihara, Kiyotake, Miyazaki 889-1692, JAPAN Miyazaki Japan 889-1692
Telephone +81-985-85-0990
E-mail hikomaru@med.miyazaki-u.ac.jp
Affiliation University of Miyazaki
Scientific contact
Name Haruhiko Maruyama
Address 5200 Kihara, Kiyotake, Miyazaki 889-1692, JAPAN Miyazaki Japan 889-1692
Telephone +81-985-85-0990
E-mail hikomaru@med.miyazaki-u.ac.jp
Affiliation University of Miyazaki Hospital